IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma.
Francesca De FelicePierfrancesco FrancoPublished in: Medical oncology (Northwood, London, England) (2023)
The aim of this editorial is to focus on the urgent need to improve clinical outcomes in patients with bulky primary anal canal carcinoma.